Cases 11 - 20 of 267
Par Pharmaceutical, Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00866
Plaintiff:
Par Pharmaceutical, Inc. and Epic Par Innovation Company, LLC
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
PROFESSIONAL DRUG COMPANY, INC. v. WYETH, INC.
as 3:2011cv05479
Defendant:
WYETH LLC, WYETH, INC., WYETH PHARMACEUTICALS, INC. and others
Not Yet Classified:
HEB GROCERY COMPANY LP, RITE AID CORPORATION, PAINTERS DISTRICT COUNCIL NO. 30 HEALTH & WELFARE FUND and others
Not Classified By Court:
FAITH HOCHBERG
In Re:
EFFEXOR XR ANTITRUST LITIGATION
Special Master:
JONATHAN J. LERNER
Interested Party:
IBEW -- NECA Local 505 Health & Welfare Plan, MC -- UA Local 119 Health & Welfare Plan, CADILA HEALTHCARE LIMITED and others
Plaintiff:
Individual Direct Purchaser Plaintiffs and PROFESSIONAL DRUG COMPANY, INC.
Petitioner:
TIMMY P. THIEN
Cause Of Action: 15 U.S.C. § 2 Antitrust Litigation
AZURITY PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al
as 3:2023cv04152
Plaintiff:
AZURITY PHARMACEUTICALS, INC., ARBOR PHARMACEUTICALS, LLC and TAKEDA PHARMACEUTICAL COMPANY LIMITED
Defendant:
ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Biogen Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00732
Plaintiff:
Biogen Inc., Biogen Swiss Manufacturing GmbH and Alkermes Pharma Ireland Limited
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 2:2023cv01369
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00266
Defendant:
Zydus Lifesciences Limited formerly known as Cadila Healthcare Limited doing business as Zydus Cadila, Zydus Pharmaceuticals (USA) Inc., Zydus Worldwide DMCC and others
Plaintiff:
Neurocrine Biosciences, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al
as 2:2023cv01685
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Defendant:
ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Exelixis, Inc. v. Zydus Pharmaceuticals USA Inc.
as 1:2023mc00132
Petitioner:
Exelixis, Inc.
Respondent:
Zydus Pharmaceuticals USA Inc.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
